This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Feagan BG, Sandborn WJ, Wolf DC, Mitchev K, Jamoul C, Rutgeerts PJ.Certolizumab pegol improves health-related quality of life in crohn's disease patients for whom infliximab treatment was not successful: results from the WELCOME study. Digestive Disease Week 2009: 179 abstr. S1058, 30 May 2009. Available from: URL: http://www.ddw.org
Rights and permissions
About this article
Cite this article
The use of certolizumab pegol improves health-related QOL (HRQOL) in patients with Crohn's disease. Pharmacoecon. Outcomes News 582, 10 (2009). https://doi.org/10.2165/00151234-200905820-00022
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905820-00022